Recordati Industria Chimica e Farmaceutica S.p.A. (VIE:REC)

Market Cap	9.96B
Revenue (ttm)	2.55B
Net Income (ttm)	404.39M
Shares Out	n/a
EPS (ttm)	1.93
PE Ratio	24.63
Forward PE	14.71
Dividend	1.30 (2.71%)
Ex-Dividend Date	Nov 24, 2025

Volume	n/a
Average Volume	n/a
Open	48.68
Previous Close	48.20
Day's Range	48.68 - 48.88
52-Week Range	44.06 - 60.25
Beta	n/a
RSI	46.50
Earnings Date	Mar 18, 2026

About VIE:REC

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally. It operates through Specialty and Primary Care; and Rare Diseases segments. The company develops REC 0545 for acute decompensation in maple syrup urine diseases; Isturia for endogenous Cushing’s syndrome; Cystadrops for corneal cystine crystal deposits; Carbaglu for hyperammonemia due ...

• Industry: Pharmaceutical Preparations
• Founded: 1926
• Employees: 4,583
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: REC

Financial Performance

In 2024, VIE:REC's revenue was 2.34 billion, an increase of 12.45% compared to the previous year's 2.08 billion. Earnings were 416.51 million, an increase of 7.01%.